<DOC>
	<DOCNO>NCT00001117</DOCNO>
	<brief_summary>This study evaluate patient infected HIV Hepatitis C virus ( HCV ) receive anti-HIV drug . The purpose study learn HCV infection patient whose HIV blood level decrease less 500 copies/ml .</brief_summary>
	<brief_title>A Study Evaluate Effects Anti-HIV Drugs HIV-Positive Patients Who Also Have Hepatitis C Infection</brief_title>
	<detailed_description>Sixty naive patient HIV confirm hepatitis C co-enrolled another AACTG antiretroviral study involve test HAART ( Highly Active Antiretroviral Therapy ) enter prospective study . Patients define naive never receive specific , active antiretroviral agent sustain viral suppression limit detection ( 500 copies/ml ) receive agent limited time . HAART define therapy likely result HIV-1 RNA plasma level less 500 copies/ml least 16 week . Plasma collect evaluate study additional quantitative measurement : Hepatitis C virus ( HCV ) HCV RNA PCR HIV-1 RNA level . All evaluation HIV-1 RNA obtain co-enrolled study follow time point : Pre-entry , entry , least 2 measurement Week 16 , Week 16 , least 1 measurement Week 16 .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive Hepatitis C. Have HIV blood level least 2,500 copies/ml 30 day study entry . Are coenrolled active adult AIDS clinical trial use antiHIV treatment . Are least 13 year age ( parent guardian consent require 18 ) . Exclusion Criteria Patients eligible study : Have liver disease . Have cancer require chemotherapy . Have Hepatitis B . Abuse alcohol and/or drug . Have receive certain antiretroviral ( antiHIV ) drug past .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2003</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>